Prescient strengthens ties with leading CAR-T research centre
Biotech company Prescient Therapeutics (ASX:PTX) had an important announcement for the market this morning, after strengthening its...
Biotech company Prescient Therapeutics (ASX:PTX) had an important announcement for the market this morning, after strengthening its...
With the number of days left to file March quarterly reports running a little short...
Melbourne biotech company Prescient Therapeutics (ASX:PTX) says a clinical trial evaluating its PTX-200 drug candidate to treat...
StockTalk is a Stockhead video series featuring a roundtable of experts discussing a new investment topic each...
There are several ASX stocks fighting cancer but only a few are addressing blood cancers....
Special Report: A form of immunotherapy that involves modifying a patient’s white blood cells so...
StockTalk is a Stockhead video series featuring a roundtable of experts discussing a new investment topic each...
Stockhead’s resident Health and Biotech expert Tim Boreham is putting down the pen and picking...
Prescient Therapeutics (ASX:PTX) has formed a cancer research partnership with the world-renowned Peter MacCallum Cancer Centre,...
Special Report: Biotech company Prescient Therapeutics is advancing to next-stage trials for its personalised treatments...
This investor centre was built by Reach Markets
©2022 Reach Markets
To stay up to date with Prescient Therapeutics news and events, please register your details.